Corrigendum to "BML-111, the lipoxin A4 agonist, modulates VEGF or CoCl2-induced migration, angiogenesis and permeability in tumor-derived endothelial cells"[Immunology Letters 230 (2021) 27-35].

Immunol Lett

Department of Pathology, Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi China. Electronic address:

Published: January 2023

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.imlet.2022.12.001	DOI Listing

Publication Analysis

corrigendum "bml-111

"bml-111 lipoxin

lipoxin agonist

agonist modulates

modulates vegf

vegf cocl2-induced

cocl2-induced migration

migration angiogenesis

angiogenesis permeability

permeability tumor-derived

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!